首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD
【2h】

miR-613 suppresses migration and invasion in esophageal squamous cell carcinoma via the targeting of G6PD

机译:miR-613通过靶向G6PD抑制食管鳞状细胞癌的迁移和侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Esophageal squamous cell carcinoma (ESCC) is a common cancer in China and has a high mortality rate. MicroRNAs (miRs) are a family of post-transcriptional regulators, which negatively regulate target gene expression. miR-613 has been revealed to be a diagnostic and prognostic biomarker in ESCC. However, the role of miR-613 in ESCC remains unclear. In the present study, miR-613 expression was identified to be reduced in tumor tissues in comparison with corresponding adjacent normal tissues. TargetScan and a dual-luciferase reporter assay verified glucose-6-phosphate dehydrogenase (G6PD) as a direct target of miR-613. In contrast with miR-613, G6PD expression was increased in tumor tissues compared with matched healthy tissues. Furthermore, overexpression of miR-613 inhibited cell migration and invasion of Eca109 cells compared with controls, while G6PD overexpression reversed the inhibition induced by miR-613, as determined by wound healing and Transwell assays. In addition, miR-613 overexpression decreased the mRNA and protein expression of G6PD, matrix metalloproteinase (MMP)2 and MMP9, and reduced the phosphorylation of signal transducer and activator of transcription 3 (STAT3) compared with controls, while G6PD reversed the effects of miR-613. However, miR-613 and G6PD did not affect the expression of STAT3. In conclusion, the aforementioned results suggest that miR-613 targets G6PD to suppress ESCC cell migration and invasion through reduced MMP2 and MMP9 expression and inactivation of the STAT3 signaling pathway. Thus, the present study may provide a new molecular foundation for treatment of ESCC.
机译:食管鳞状细胞癌(ESCC)是中国常见的癌症,死亡率很高。 MicroRNA(miR)是转录后调节剂的一个家族,对靶基因的表达产生负调控。 miR-613已被证明是ESCC的诊断和预后生物标志物。但是,miR-613在ESCC中的作用仍不清楚。在本研究中,与相应的邻近正常组织相比,在肿瘤组织中发现miR-613表达降低。 TargetScan和双重荧光素酶报告基因检测证实了6磷酸葡萄糖脱氢酶(G6PD)是miR-613的直接靶标。与miR-613相反,与匹配的健康组织相比,G6PD在肿瘤组织中的表达增加。此外,与伤口相比,miR-613的过表达抑制了Eca109细胞的细胞迁移和侵袭,而G6PD的过表达逆转了miR-613诱导的抑制作用(通过伤口愈合和Transwell分析确定)。此外,与对照组相比,miR-613的过表达降低了G6PD,基质金属蛋白酶(MMP)2和MMP9的mRNA和蛋白表达,并降低了信号转导子和转录激活子3(STAT3)的磷酸化,而G6PD则逆转了miR-613。但是,miR-613和G6PD并不影响STAT3的表达。总之,上述结果表明,miR-613通过降低MMP2和MMP9的表达以及STAT3信号通路的失活来靶向G6PD,以抑制ESCC细胞的迁移和侵袭。因此,本研究可能为ESCC的治疗提供新的分子基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号